Bain Capital Life Sciences Investors, LLC - 10 Aug 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
10%+ Owner
Signature
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, By: /s/ Chris Green, Title: Managing Director
Issuer symbol
SWTX
Transactions as of
10 Aug 2021
Net transactions value
-$70,250,000
Form type
4
Filing time
12 Aug 2021, 20:38:04 UTC
Previous filing
21 Jul 2021
Next filing
05 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Sale $70,250,000 -1,000,000 -17% $70.25 4,831,307 10 Aug 2021 See footnotes F1, F2, F3
holding SWTX Common Stock 1,106 10 Aug 2021 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock held directly by BC SW, LP.
F2 Bain Capital Life Sciences Investors, LLC ("BCLSI"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, LP. As a result, each of BCLSI, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, LP. BCLSI, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of its or their pecuniary interest therein.
F3 Jeffrey Schwartz is a director of the Issuer.
F4 Represents a restricted stock award held directly by Jeffrey Schwartz.